Anti-Human MET monoclonal antibody (CABT-35309RH)
Rabbit Anti-Human MET monoclonal antibody for WB, ICC/IF, IHC, FC
Bring this labeled antibody directly to your bench!
Online Inquiry Add to basket
Recommended Dilution: WB: 1:1,000-1:5,000; ICC: 1:50-1:200; IHC: 1:50-1:200; FC: 1:50-1:100
*Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own experiment using appropriate negative and positive controls.
Fig1: Western blot analysis of Met on different lysates using anti-Met antibody at 1/1,000 dilution.
Lane 1: Hela;
Lane 2: HepG2
Fig3: Immunohistochemical analysis of paraffin-embedded human tonsil tissue using anti-Met antibody. Counter stained with hematoxylin.
Fig2: ICC staining Met in Hela cells (green). The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.
Fig4: Immunohistochemical analysis of paraffin-embedded human lung cancer tissue using anti-Met antibody. Counter stained with hematoxylin.
Fig5: Immunohistochemical analysis of paraffin-embedded human liver cancer tissue using anti-Met antibody. Counter stained with hematoxylin.
Fig6: Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using anti-Met antibody. Counter stained with hematoxylin.
Fig7: Flow cytometric analysis of Hela cells with Met antibody at 1/50 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black). Alexa Fluor 488-conjugated goat anti rabbit IgG was used as secondary antibody
AUTS9; c met; D249; Hepatocyte growth factor receptor; HGF; HGF receptor
Have you cited CABT-35309RH in a publication? Let us know
and earn a reward for your research.
LoRusso, PM; Krishnamurthi, S; et al. Icrucumab, a fully human monoclonal antibody against the vascular endothelial growth factor receptor-1, in the treatment of patients with advanced solid malignancies: a Phase 1 study. INVESTIGATIONAL NEW DRUGS 32:303-311(2014).
Spadaro, A; Lubrano, E; et al. The adherence to ASAS classification criteria and to ASAS recommendations for the use of anti-TNF-alpha agents in axial spondyloarthritis. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 32:465-470(2014).
Custom Antibody Labeling
We offer labeled antibodies using our catalogue antibody products and a broad range of intensely fluorescent dyes and labels including HRP, biotin, ALP, Alexa Fluor® dyes, DyLight® Fluor dyes, R-phycoerythrin (R-PE), at scales from less than 100 μg up to 1 g of IgG antibody.